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Peritonealdialysis(PD)wastheﬁrstmodalityused forrenalreplacementtherapy (RRT) ofpatientswithacutekidneyinjury(AKI)
because ofitsinherentadvantages ascompared toHemodialysis.Itprovides thenephrologistwithnonvascularalternativeforrenal
replacement therapy. It is an inexpensive modality in developing countries and does not require highly trained staﬀ or a complex
apparatus. Systemic anticoagulation is not needed, and it can be easily initiated. It can be used as continuous or intermittent
procedure and, due to slow ﬂuid and solute removal, helps maintain hemodynamic stability especially in patients admitted to
the intensive care unit. PD has been successfully used in AKI involving patients with hemodynamic instability, those at risk of
bleeding, and infants and children with AKI or circulatory failure. Newer continuous renal replacement therapies (CRRTs) are
being increasingly used in renal replacement therapy of AKI with less use of PD. Results of studies comparing newer modalities of
CRRT versus acute peritoneal dialysis have been conﬂicting. PD is the modality of choice in renal replacement therapy in pediatric
patients and in patients with AKI in developing countries.
1.Introduction
Acute kidney injury occurs in hospitals and is seen in
up to 5% of hospitalized patients. 0.5% of the patients
with AKI require dialysis [1]. Acute kidney injury occurs
more frequently in intensive care unit (ICU) as part of
the multiorgan failure and is usually associated with higher
mortality rate and increased dialysis requirement in ICU
setting.
There are two major types of dialysis available these days:
Peritoneal dialysis (PD) and Hemodialysis (HD). PD was the
modality ﬁrst used fortreatment ofAKI[2]. Intermittent PD
was widely used in the 1970s due to its various advantages.
Later, continuous PD therapies became available through
automated cycling machines (cyclers).
Inwestern countries, peritoneal dialysisisnot commonly
used in dialytic management of acute kidney injury due to
the availability of newer HD techniques and development of
continuous renal replacement therapies (CRRTs). The new
technological advances in the extracorporeal circuit of HD
successfully compete with traditional advantages of PD. The
limiting factors are the slow eﬃciency of the procedure,
limitedvalueinpatientswithrecentintra-abdominal surgery
or intra-abdominal pathology, and rise in intra-abdominal
pressure which may compromise pulmonary function. The
rise in intra-abdominal pressure may have deleterious eﬀects
in patients with acute lung injury or the acute respiratory
distress syndrome (ARDS). High glucose content of the
PD solution can evoke hyperglycemia and other metabolic
derangements. Increased carbon dioxide production is asso-
ciated with an increase in respiratory quotient to >1.0
which may exacerbate respiratory failure in patients with
compromised lung function.
This paper paper covers the use of peritoneal dialysis
in the setting of AKI especially regarding indications,
various techniques, prescription of acute PD, and various
complications encountered during the procedure.
2.IndicationsofAcutePD
The indications for acute PD can be divided into two groups:
renal and nonrenal.
2.1. Renal Indications. Peritoneal dialysis is an advantageous
modality for RRT in AKI (Table 1). It is indicated in both2 International Journal of Nephrology
Table 1: Renal indications of peritoneal dialysis in AKI.
(1) RRT in the treatment of AKI in children
(2) Hemodynamically unstable patients
(3) The presence of bleeding diasthesis or hemorragic conditions
contraindicating placement of vascular access for hemodialysis or
anticoagulation
(4) Patients with diﬃcult vascular access placement
(5) Removal of high molecular weight toxins (10kD)
Table 2: Nonrenal indications.
(1) Acute pancreatitis
(2) Clinically signiﬁcant hypothermia or hyperthermia
(3) Refractory heart failure
(4) Liver failure
(5) Infusion of drugs and nutrients as a supportive therapy in
critically ill patients
renal and nonrenal-related conditions where it is indicated
due to advantages of the PD modality. PD can easily meet
treatmentgoalsforAKIpatients,maintaining adequateﬂuid,
electrolyte, and acid base balances. It also allows the use of
other supportive measures like use of intravenous infusion
of sedatives, vasopressors in hemodynamically unstable
patients, and total parenteral nutrition to continue without
limitation until the recovery of renal function. However, as
compared to HD, PD is less eﬀective in severe acute illnesses
like pulmonary edema, poisoning, or drug overdose, and
hypercatabolic states.
Usually small molecular clearance is lower with PD
than that achieved with conventional HD. This is because
small molecule concentration in peritoneal dialysate is
approximately30%–50%oftheequivalentserumvaluesafter
1 hour of PD and 50%–80% after a 4-hour dwell [3]. On the
other hand, the clearance of higher molecular weight solutes
is higher with continuous PD than with HD [4].
The ultraﬁltration rate is maximal at the beginning of a
PD exchange when glucose concentration is at its maximum.
As the glucose is absorbed and its concentration further
drops due to movement of ultraﬁltrate into the peritoneal
cavity, there is further fall in the ultraﬁltration rate. As a
result of which the intraperitoneal volume peaks at about
120–180 minutes of dwell.
Acute PD is the preferred mode of RRT in children [5].
In patients with hemodynamic instability due to various
reasons, PD is preferable to conventional HD [6]. PD can
meet treatment targets for AKI and can maintain adequate
ﬂuid, electrolyte, solute clearances, and acid base balance in
patients with AKI.
Earlier studies have shown that patients treated with PD
had lower mortality rates and a higher incidence of renal
recovery than did similar patients treated with HD [7, 8].
2.2. Nonrenal Indications for Acute PD. PD can be used in
various extra renal conditions (Table 2). In acute hemor-
rhagic pancreatitis, PD helps in the removal of bioactive
Table 3: Peritoneal dialysis is contraindicated in the following
clinical Situations.
(1) Recent abdominal surgery
(2) Pleuroperitoneal communication
(3) Diaphragmatic severe respiratory failure
(4) Life-threatening hyperkalemia not responding to medical
therapy
(5) Extremely hypercatabolic state
(6) Severe volume overload in a patient not on a ventilator
(7) Severe gastroesophageal reﬂux disease
(8) Low peritoneal clearance
(9) Fecal or fungal peritonitis
(10) Abdominal wall cellulitis
(11) AKI in pregnancy
substances presumed to be responsible for systemic inﬂam-
mation associated with acute pancreatitis [9–11]. However,
a multicenter prospective study found no diﬀerence in the
mortality or complication rate for patients who received
standard supportive therapy with or without hourly 2-L
peritoneal dialysis exchanges for 3 days [12].
Clinically signiﬁcant hypothermia or hyperthermia can
be managed with PD where heated or cold peritoneal
solutions can be used to maintain core temperature. This
is usually done in patients with either hypothermia or
hyperthermia who do not respond to conventional therapy
[13–15].
Congestive Heart Failure (CHF) refractory to medical
therapy can be treated with peritoneal dialysis when there
is inadequate response to diuretics in severely volume
overloaded state [16–19].
In patients with fulminant liver failure, PD has been
used because it avoids need for anticoagulation. It corrects
ﬂuid and electrolyte disorder and may reduce the risk of
hypoglycemia and hypothermia as compared to charcoal
hemoperfusion [9]. PD may help in the removal of toxins
like ammonia, bilirubin, and free fatty acids.
PD may be used as route for delivery of nutrients like
glucose and amino acids and certain drugs in severely ill
patientsadmittedtointensivecareunit.Thisroutealonemay
not be enoughin severely malnourished individuals [20–22].
3.Contraindicationsto AcutePD
There are several relative contraindications to acute PD
(Table 3), such asrecent abdominalsurgery, peritonitis(fecal
or fungal), and known pleuroperitoneal ﬁstula. Presence of
abdominal drain increases the risk of local infection. The
presence of abdominal hernia or intra-abdominal adhesions
makes PD diﬃcult.
TheuseofPDisrelativelycontraindicatedinthepresence
of the abdominal wall cellulitis which may progress to peri-
tonitis. It is also contraindicated in severe gastroesophageal
reﬂux disease, and in adynamic ileus which may decrease
eﬃciency of peritoneal dialysis. In patients with relative
respiratory insuﬃciency, the use of intraperitoneal ﬂuid mayInternational Journal of Nephrology 3
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Figure1: Basicmechanismsoperatinginvariousperitoneal dialysis
regimens.
increase intra-abdominal pressure and hence compromise
lung function and respiratory gas exchange. Acute PD is
ineﬀective in treatment of life threatening hyperkalemia
[23] .U s eo fP Di nl i f et h r e a t e n i n gH y p e r k a l e m i as h o u l db e
reserved in situations when HD is not available. It is not the
best modality of RRT in hypercatabolic patients with a high
load of azotemia [24].
4.Regimensof AcutePD
PD can be performed intermittently or continuously and
either manually or via an automated device [25]. Perfor-
mance of acute PD requires only an intact peritoneal cavity
[25]. Various regimens of acute PD are shown in Figure 1.
4.1. IPD (Classical Intermittent Peritoneal Dialysis). IPD is
themostcommonlyused regimen ofPD.The usualexchange
time is 1 hour. It can be done either manually or by using
a cycling device programmed to deliver a predetermined
volumeofperitonealdialysisﬂuidandtodraintheperitoneal
cavity at ﬁxed intervals. Short exchanges of 1-2L performed
in sessions of 16–24 hours twice or three times weekly can
deliver doses of about 40–60L per session (80–180L/week).
This type of PD has been extensively used in ARF [24, 26].
4.2. CPD (Continuous Peritoneal Dialysis). It is a modiﬁed
form of CAPD in which manual exchange is done every 3–6
hours depending upon patient clearance and ﬂuid removal
requirements. It provides PD in an inpatient setting [27]. It
isa simpleprocedure,has lowcost,andis less laborintensive.
It diﬀers from IPD because it uses relatively long dwell
times and uses multiple daily exchanges, in which peritoneal
dialysis ﬂuid is instilled and drained continuously every 3–
6 hours. These exchanges can be performed manually or by
a cycler. It maintains a low ﬂow continuous system, which
itself maintains stable blood levels of nitrogenous products.
It is commonly done in developing countries because of the
low cost and is less labor intensive. The disadvantage is that
clearances may not be adequate especially in hypercatabolic
patients because of a lower dialysate ﬂow rate.
4.3. TPD (Tidal Peritoneal Dialysis). With this technique,
after an initial exchange of the peritoneal cavity with peri-
toneal dialysis ﬂuid, only a portion of dialysate is drained.
The drained volume is replaced by fresh dialysate with each
cycle leaving a variable amount of dialysate in constant
contact with the peritoneal membrane until the end of
dialysis session when the ﬂuid is drained as completely
as possible. Tidal PD was originally designed to optimize
solute clearances [28] by leaving constant tidal volume of
dialysate in the peritoneal cavity throughout the dialysis
session. Clinical studies have not conﬁrmed increased solute
clearance with use of TPD [29–31]. The tidal volume is
usually one half of initial ﬁlling by the cycler of a large (2-
L) volume of solution during a dialysis session that lasts for
8–10 hours.
5. PeritonealAccess
Access is one of the important determinants of successful
peritoneal dialysis. A peritoneal catheter is inserted in the
peritoneal cavity to gain access to the peritoneal space for
initiation of dialysis.
There are two diﬀerent types of peritoneal catheters.
(1) Semirigid Acute Catheter. This can be inserted at bedside
by a nephrologist and does not need surgical help [32]. It
is usually inserted under local anesthesia and hence avoids
complications of general anesthesia. The major disadvan-
tages are high risk of infection, discomfort in an awake
patient, and risk of bowel perforation. This type of catheter
cannot be left in place for more than 72 hours due to high
risk of peritonitis [32, 33].
(2) Cuﬀed Permanent Catheter. This is usually a Tenckhoﬀ
catheter. It has a much lower risk of infection, can be
used immediately after insertion, has a lower risk of bowel
perforation, and avoids the need for repeated punctures
in intra-abdominal cavity as with semirigid catheters. This
catheter is preferred in patients with acute PD on a cycler
because this catheter does not trigger alarms on CCPD as
sometimes experienced with use of semirigid catheters.
This type of catheter is placed under local anesthesia and
requires surgical expertise for insertion. The hemodynamic
status of the patient may limit the feasibility of this catheter
especially in sick ICU patients.
6.AcutePeritonealDialysis Prescription
After the insertion of an acute or chronic peritoneal catheter
preferably chronic if possible, PD orders need to be individ-
ualized depending upon hemodynamic status of the patient,
laboratory work, and volume status. A standardized form
with complete and clear speciﬁcations for procedure should
be used if available (Table 7). PD orders must be reviewed
andwritten dailyaspatientswith AKIcanﬂuctuatetheiracid
base and electrolyte milieu. The components of PD orders
are multiple and involve the following (Table 4).
A usual dialysis session lasts for 48–72 hours and each
exchange is done over one hour. A typical session of acute
peritoneal dialysis has 48–72 exchanges. However, the length
of a PD session can vary depending on the cause and4 International Journal of Nephrology
Table 4: Components of acute PD prescription.
(1) Length of the dialysis session
(2) Dialysate composition
(3) Exchange volume
(4) Inﬂow and outﬂow periods
(5) Dwell time
(6) Number of exchanges
(7) Additives
(8) Monitoring of ﬂuid balance
Table 5: Composition of peritoneal dialysis ﬂuid.
(1) Sodium 132–134 (mmol/L)
(2) Potassium0–2 (mmol/L)
(3) Calcium 1.25–1.75 (mmol/L)
(4) Magnesium 0.25–0.75 (mmol/L)
(5) Chloride 95–106 (mmol/L)
(6) Lactate 35–40 (mmol/L) or HCO3 (34mmol/L)
(7) Glucose 1.5–4.25 (g/dL)
(8) pH (Neutral and physiological in newer peritoneal dialysis
ﬂuid preparations)
duration of AKI, need for water and solute removal, and the
risk of infection.
PD ﬂuid (PDF) is available in standard monohydrate
glucose concentrations of 1.5, 2.5, and 4.25g/dL and various
electrolyte concentrations (Table 5). PD ﬂuid should be
warmed to body temperature prior to infusion to avoid
discomfort and enhance solute transport.
To obtain better ultraﬁltration, it is reasonable to initiate
acute PD in most patients with the 2.5g/dL PD ﬂuid.
An initial glucose concentration of 1.5g/dL may be more
appropriate in patients with only moderate amounts of ﬂuid
overload and in those who are hemodynamically unstable.
PD ﬂuid with a higher glucose concentration can be
substituted based on the amount of ﬂuid removed and
the patient’s hemodynamic parameters. With a standard
regimen, such as a two-liter exchange volume and one-hour
dwell time, the following average amounts of ﬂuid can be
removed over a 24-hour period:
(i) 2.5 liters with 1.5g/dL glucose,
(ii) 4.5 liters with 2.5g/dL glucose,
(iii) 8.5 liters with 4.25g/dL glucose.
Various types of glucose concentration are available to
use in acute PD prescription (Table 6).
(i) 1.5g/dL PD ﬂuid contains 27.2 grams of glucose in 2
liter bag. It usually gives ultraﬁltration of 50–150mL
per hour when using a 2-L exchange volume over 60-
minute exchange time. It is the most commonly used
ﬂuid in acute PD.
(ii) 2.5g/dL PD ﬂuid can give UF of 100–300cc per
exchange volume of 2L and exchange time of one
hour. 2L bag of 2.5g/dL of PDF contains 45.4 grams
of glucose.
(iii) 4.25g/dL PD ﬂuid contains 77.2 grams of glucose
in 2 liter bag and can give rise to UF of 300–
400cc/exchange. This hypertonic ﬂuid is usually
used in patients with volume overload like CHF.
Continued use of the 4.25g/dL ﬂuid could result
in removal of 7.2–9.6L per day which can be
very dangerous since it can induce hemodynamic
instability due to massive ultraﬁltration, and high
glucose content of hypertonic PDF is deleterious to
the peritoneal membrane. This degree of UF is not
required usually and one can use combination of
glucose concentrations to attain level of UF desired.
The most practical way to achieve ﬂuid removal is by
mixing and matching low and high glucose concentration
adequate ﬂuid. Once the patient is euvolemic, the dialysis
ﬂuid should be switched to a glucose concentration of
1.5g/dL and the rate of exchange should be slowed.
Exchange volume is the amount of PD ﬂuid instilled
into the peritoneal cavity during an exchange. The volume
instilled depends on the intraperitoneal pressure (IPP), the
presence of pulmonary disease or mechanical ventilation,
and thepresenceofabdominalhernia. An averagesized adult
can tolerate 2-L exchanges but in smaller patients, those
with pulmonary disease or those with abdominal or inguinal
hernias, theexchangevolumeshouldbereduced.Inpediatric
patients with AKI requiring dialysis, exchange volume is
based on body weight. Usually volume of 30mL/Kg body
weight is used for PD.
The intraperitoneal pressure rises linearly with higher
volume of intraperitoneal ﬂuid used. Intraperitoneal pres-
sure is higher in patients with higher body mass index.
Age, gender, weight, height, body surface area (BSA), and
Diabetes Mellitus, do not correlate with IPP [34]. The
peritonealdialysisﬂuidvolumeshouldbereducedinpatients
with a pulmonary disease (like pneumonia or COPD) or
respiratory failure. The rise in intra-abdominal pressure due
to PD ﬂuid may hamper diaphragmatic excursions needed
for respirations. Similarly, patients with abdominal wall or
inguinal hernia may require less volume to prevent a rise
in intra-abdominal pressure. Low PDF volume is used after
the PD catheter placement to avoid leakage. The volume
is gradually increased over the next three or four days as
tolerated by the patient.
Inﬂow time is the time required to instill the PD ﬂuid
into the peritoneal cavity under the eﬀect of gravity. The
time is usually 10–15 minutes [25]. It depends on amount of
ﬂuidtobeinfused, heightofthebagfrom patient’sabdomen,
and resistance to ﬂow due to the kinking of the catheter or
reduced bowel motility. The inﬂow time should be kept to
minimal to maximize eﬃciency of peritoneal dialysis.
Dwell time is the time period for which the exchange
volume stays in the intraperitoneal cavity for diﬀusion and
ultraﬁltration which is usually 30 minutes in single acute
peritoneal dialysis exchange. A dwell time of less than 30
minutes is usually not adequate [35]. The dwell time for
patients on acute CPD is about 3–6 hours which can beInternational Journal of Nephrology 5
Table 6: Dialysis ﬂuid glucose concentration.
Glucose (monohydrate) Fluid osmolarity Ultraﬁltrate volume
g/dL mOsm/L mL per exchange over one hour
1.5g/dL 346 50–150
2.5g/dL 396 100–300
4.25g/dL 485 300–400
shortened to increase the total number of exchanges to
improve solute clearance.
Outﬂow time is the time required to drain eﬄuent
dialysate after dwell which takes place under eﬀect of gravity.
It is usually takes 20–30 minutes to complete [25]. Outﬂow
is aﬀected by volume of the eﬄuent to be drained, outﬂow
resistance to drainage, and height diﬀerence between patient
and drainage bag. One should ensure complete drainage
as incomplete drainage can cause a rise in intra-abdominal
pressure causing respiratory embarrassment or abdominal
discomfort.
The number of exchanges depends on the amount of
ﬂuid and solute removal required for a particular patient.
The usual number of exchanges is about 24 per day with
standard acutePD and approximately 4–6perday with CPD.
Some drugs can be added to the PD ﬂuid to treat certain
speciﬁc conditions. Some of these drugs are the following.
Heparin. Heparin is used to prevent clot formation. Usually
a dose of 500 units/liter is used [36]. Usually, heparin is
also used when plugs or strands of ﬁbrin are visible on
the drained ﬂuid. Heparin is more beneﬁcial when added
prophylactically. No systemic anticoagulation risk exists
when heparin is used through a PD catheter as there is no
systemic absorption of heparin through peritoneum.
Insulin. Usually insulin is used in diabetic patients on PD
for glycemic control. The glucose content of the PD ﬂuid
can worsen hyperglycemia especially with hypertonic ﬂuid,
which can result in very high blood glucose levels. Intraperi-
toneal insulin is usually addedt ot h eP Dﬂ u i d ,a n dt h ed o s e
is adjusted based on frequent blood glucose monitoring.
Insulin should not be added in last 2-3 exchanges to prevent
postdialysis hypoglycemia.
A usual regimen comprises of an increasing insulin dose
in the dialysis bag with increasing glucose concentration as
follow:
4-5 units/L for 1.5g/dL PD ﬂuid,
5–7 units/L for 2.5g/dL PD ﬂuid,
7–10 units/L for 4.25g/dL PD ﬂuid.
Potassium. Normally, there is no Potassium in the dialysis
ﬂuid but potassium can be added to the PD ﬂuid in
hypokalemic patients. Usually 3-4meq/L is added to main-
tain normokalemia [36].
Antibiotics. Intraperitoneal administration of antibiotics is
eﬃcient and provides an alternative route for patients with
poor vascular access and for those with peritonitis. A variety
of antibiotics can be administered through PD intraperi-
toneally. It is very important to maintain accurate ﬂow
sheets, maintain intake/output charts, and document net
ultraﬁltration in patients on acute PD. Intraperitoneal route
is preferred to intravenous dosing for treating peritonitis.
Both intermittent and dosing of antibiotics are equally
eﬃcacious. Empiric treatment of peritonitis should start
immediately and should have both gram-positive and gram-
negative coverage. In case of intermittent therapy, these
antibiotics should be given intraperitoneally and allowed
to dwell for 6 hours. First generation cephalosporin or
Vancomycin can be used for gram-positive coverage and
either third generation cephalosporin or aminoglycoside
should be used to cover gram-negative organisms. Results
of culture and sensitivity should be followed and antibiotics
shouldbechangedbasedonsensitivity oftheorganism. Most
patients show considerable clinical improvement within 48
hours of initiation of antibiotic treatment. Total duration of
antibiotic therapy forperitonitisdependsuponthe organism
isolated and ongoing results of peritoneal ﬂuid cell count
and repeat culture. The reader should refer to International
Society of Peritoneal Dialysis guidelines regarding doses
of various antibiotics used intraperitoneally in PD for
treatment of peritonitis [37].
7.ComplicationsofPD
Acute PD may be associated with infectious, mechanical, or
medical complications of varying severity [38, 39]. A brief
overview of the complications is discussed in this section.
7.1. Infectious Complications. P e r i t o n i t i so c c u r si nu pt o
12% of cases frequently developing within ﬁrst 48 hours
of therapy [40]. It usually occurs with an open drainage
system and is due to contamination of the connection or
disconnection of each new exchange. It can be caused by
both gram-positive and gram-negative bacteria. Peritonitis is
usually suspected when the eﬄuent is cloudy. The diagnosis
is conﬁrmed by PDF analysis for cell count, gram staining,
and culture and sensitivity. Antibiotic therapy should be
initiated as soon as possible empirically to avoid serious
consequences of peritonitis like sepsis, catheter removal, and
so forth. One can narrow downthe antibioticadministration
based on results of culture and sensitivity of PDF.
7.2. Mechanical Complications
Pain. Pain is usually experienced at the incision site or may
be associated with manipulation of the catheter during the6 International Journal of Nephrology
Table 7: Acute peritoneal dialysis orders.
Nephrologist should make sure that PD catheter is adequately inserted preferably chronic catheter and has no issues with ﬂow of the
ﬂuid. PD orders need to be individualized depending upon hemodynamic status of the patient, laboratory work, and volume status.
PD orders need to be reviewed and written daily as patients with AKI usually ﬂuctuate acid base and electrolyte balance daily
Nursing orders
Dialysis session length ......hours
Dialysis volume per exchange ......L
Dialysis dextrose concentration %
Inﬂow time ......min Dwell time ......min, Outﬂow time ......min
Vital signs q ......hours
Weigh patient q ......hours
Warm dialysate ﬂuid to body temperature
Maintain strict intake and output
Additives to dialysate Heparin yes/no, Insulin yes/no, Potassium yes/no
Medication dose frequency
Vancomycin ......mg/L of exchange, Tobramycin ......mg/L of exchange other antibiotic ......mg/L
Catheter care and dressing change every day
Full chemistry panel including blood glucose level to be done every 12 hours each day during dialyisis
Send 15 cc of dialysate ﬂuid from catheter every morning during dialysis and send it for cell count with diﬀerential, gram staining,
and culture and sensitivity yes/no
Renal Physician to be notiﬁed immediately for the following situations:
Poor dialysate ﬂow
Severe abdominal pain or distention
Change in color of dialysate, bloody, or cloudy drainage
Dialysate leak or purulent drainage around catheter exit site
Patient hypotensive with systolic blood pressure of <......mm Hg
Respiratory rate of ≥ ......per minute or severe shortness of breath in non ventilated patient
Temperature of ≥ ......C
Two consecutive positive exchanges
Single positive exchange balance (dialysate IN-dialysate OUT) of >1000mL
If negative balance exceeds ......Lo v e r......hours
Notiﬁcation of abnormallaboratory values
procedure. Pain may be due to multiple factors such as low
pH of PD ﬂuid, low temperature, the jet ﬂow from a straight
catheter tip, or distension of the tissue around the catheter.
This pain may be minimized by infusion of alkaline PD ﬂuid
with the addition of sodium bicarbonate and by raising the
temperatureofthePDFbywarmingorslowingdowntherate
of the infusion of ﬂuid.
Perforation. Perforation of various abdominal viscera can
occur during the insertion of the peritoneal dialysis catheter.
Usual organs at risk of perforation are bowel and uri-
nary bladder. Bowel perforation is manifested by severe
abdominal pain, leak of intestinal contents, or urine in
case of urinary bladder perforation through the catheter
stylet. The diagnosis of the perforated organ may be evident
immediately after the event or it may remain silent for
some time, leading to other complications. Peritoneoscopic
or surgical implantation of the catheter should reduce the
incidence of perforation.
Blood in Dialysate. Bloody dialysate can occur due to a
bleeding tendency in the patient’s body. Bleeding can result
from laceration of anterior abdominal wall vessels (i.e.,
inferior hypogastric artery) or less frequently, puncture of
intraabdominal vessels. The treatment of bleeding depends
on its severity. Usually, frequent exchanges and use of
intraperitoneal heparin to preventclottingare generally used
until the eﬄuent clears or surgical intervention is deemed
necessary. Bleeding due to laceration of the abdominal wall
can be controlled through ligation of the vessel through
either laparoscopy or laparotomy.
Early Dialysate Leakage. Incidence of pericatheter leaks can
vary from 0–40%. Pericatheter leaks may not be apparent in
the immediate postinsertion period unless a full exchange is
performed. Catheter leak usually occurs due to the presence
of certain predisposing factors like old age, obesity, diabetes
mellitus, chronic steroid use, and multiparity. It is usually
avoided by using low ﬁll volumes. The risk of leak is low inInternational Journal of Nephrology 7
supinepositionbecauseintraperitoneal pressureisthelowest
in this position as compared to sitting or standing. Catheter
leaks can be prevented with use of tightly secured purse
string sutures at the site of entrance of the catheter into the
peritoneal cavity and by precisely placing the catheter cuﬀs.
Sutures should never be placed at exit site skin to prevent
leak.
Respiratory Insuﬃciency. Respiratory distress usually occurs
due to abdominal distension as the instillation of peritoneal
ﬂuid causes a rise in intra-abdominal pressure. It can
be prevented by careful observation to ensure complete
emptying during the allowed drainage period.
Extravasation of Fluid in Tissue Compartments. Extravasa-
tion ofﬂuidis usually in the abdominal wall. This sometimes
presents as genital edema. It is usually due to peritoneal
defects at the site of catheter insertion. It is suspected when
there is a reduced amount of drainage volume, increased
abdominal girth, and increased body weight without edema
appreciated elsewhere in the body. Imaging studies are
neededtodiagnosetheunderlyingcauseoftheextravasation.
Hydrothorax. PD-related Hydrothorax was ﬁrst described
in 1967 by Edwards and Unger [41]. The prevalence of
Hydrothorax varies ranging from 1.6% [42] to 6% of adult
PD patients [43]. Usually pleural eﬀusion is transudate in
nature, and it occurs usually immediately after starting PD
or a few days later [44]. Hydrothorax is usually right sided
and is due to the presence of a congenital diaphragmatic
defect with a subsequent pleuroperitoneal communication,
disorder of lymphatic drainage, and pleuroperitoneal pres-
sure gradient [44–46]. The glucose concentration of the
pleural ﬂuid is usually greater than the glucose level in
the serum although this is not always a consistent ﬁnding.
Diagnosis of pleuroperitoneal communication may require
use of radionuclide scanning with technetium. Severe cases
may require cessation of PD and surgical closure of the
communication, pleurodesis by talc insuﬄation, or video-
assisted thoracoscopic pleurodesis.
7.3. Medical Complications
Fluid, Electrolyte, and Acid Base Disturbances. Complica-
tions related to ﬂuid and electrolyte can be avoided by
close monitoring of the changes in patient’s body weight,
documentation of dialysis regimen pertaining to dialysis
exchange frequency, osmotic strength of ﬂuid used, volume
of PDF used per exchange, and ultraﬁltration. Daily intake
and nonurinary output records should be reviewed on a
daily basis. Hypernatremia is usually caused by the sieving
eﬀect with ultraﬁltrate being formed with much lower
concentrationofsodiumthanthatofplasma.Hypernatremia
usually can be alleviated by the use of glucose containing
ﬂuids. Lactic acidosis is rare except in patients with terminal
liver failure. Lactic acidosis can be avoided by the use of
bicarbonate containing peritoneal dialysis ﬂuid in patients
with terminal liver failure. Occasionally, severe lactic acidosis
can be due to ongoing bowel ischemia and should be
excluded under relevant clinical conditions.
Hypervolemia and Hypovolemia. Volume changes can occur
due to the use of either hyperosmotic ﬂuid or due to
ultraﬁltration failure. This can be alleviated by adjusting the
prescription of dialysis or in some situations may require
temporarycessationofdialysis.Hypervolemiaduetoultraﬁl-
tration failureisusuallyseen inhighsolutetransporters. This
particular ultraﬁltration failure can be seen during episodes
of acute peritonitis.
Hypoalbuminemia. Albumin loss is seen due to high protein
losses in the dialysate especially during episodes of peritoni-
tis. These losses can be as high as 10–20 grams a day and
patients may require protein supplementation either orally
or intravenously.
8.OutcomeofPatientson
AcutePeritonealDialysis
This section will review recent studies conducted in AKI
patients treated with acute PD alone for dialytic therapy and
the studies comparing acute PD with other modalities of
renal replacement therapies. Two recent studies conducted
in AKI patients using acute PD have given promising
results. One prospective study [47] with 30AKI patients was
performed in Brazil. The purpose of the study was to explore
role of high volume continuous peritoneal dialysis (CPD)
in patients with AKI, analyzing metabolic abnormality,
resolution of ﬂuid balance, and patient outcome.All patients
had AKI due to ischemic or nephrotoxic Acute Tubular
Necrosis (ATN). Adequacy of dialysis was measured by
formula Kt/V(where K is rate ofurea clearance by peritoneal
membrane in litres, t is the treatment duration (24 hours),
and V is volume of body urea distribution in litres). The
prescribed Kt/V value was 0.65 per session. In this study
patients were assigned to high-dose continuous peritoneal
dialysis (CPD) via a ﬂexible PD catheter and automated
PD with a cycler. PD exchanges were done with two liter
peritoneal ﬂuid using 35–50 minute dwell time with total of
36–44 Liters of PDF per day. Biochemical parameters (Urea,
Creatinine, pH, Potassium and Bicarbonate) were measured
twice daily. Patients received 236 CPD sessions resulting in
normalized creatinine clearance and urea Kt/V values of
110 ± 22.5a n d3 .8 ± 0.61 per week per 1.73m2 body surface
area, respectively. After 4 days of CPD, patients had stable
BUN value <50mg/dL and creatinine at <4mg/dL.Inthis
study, 57% of the patients died and 23% of the patients
recovered their renal function. The authors concluded that
high-dose CPD using ﬂexible PD catheter and automated
PD with a cycler was an eﬀective therapy for AKI which
provides appropriate metabolic and acid-base control as well
as adequate dialysis dose and ﬂuid removal.
Another prospective, randomized, crossover study [48]
from India enrolled 87 hemodynamically stable patients
with AKI (88% of AKI in this study was due to medical
reasons). Two diﬀerent modalities of PD, Tidal PD (TPD),8 International Journal of Nephrology
versus continuous peritoneal dialysis (CPD) were done in
patients with mild to moderate hypercatabolism. Severely
hypercatabolic and hemodynamically unstable patients were
excluded from the study. Patients received either TPD or
CPD after insertion of rigid peritoneal dialysis catheter.
If there was a need to continue PD in patients with no
recovery of renal function, patients were crossed over to
othermodality ofPD after washout period of 14 hours. Total
volume of PDF used daily was 26L by using 2L bags with
dwell time of 210 minutes in CPD group and 10-minute
dwell in TPD group. Patients completing at least one set
of dialysis (CEPD + TPD or TPD + CPD) were included
in ﬁnal analysis. The study showed that diﬀerent modalities
of PD are adequate methods to maintain BUN levels at
65mg/dL in mild to moderate hypercatabolic AKI patients
from developing countries. Other studies done in the past in
patients with AKI have shown similar results [24, 49].
Studies comparing acute PD to other modalities of
renal replacement therapy are limited and the results of
the conducted studies are conﬂicting. Phu et al. [50]
performed an open, randomized comparison of pumped
venovenoushemoﬁltrationandperitonealdialysisinpatients
withinfection-associated AKIinaninfectiousdiseasereferral
hospital in Vietnam. The primary outcome in this study was
to assess rapidity of resolution of metabolic abnormalities
like correction of academia and creatinine level between the
two modalities in patients with AKI. Secondary end points
were death, need for further renal replacement therapy,
incidence of serious complications, and cost of treatment.
This study included patients with AKI due to sepsis (48
patients with severe Falciparum Malaria, 22 patients with
sepsis).Childrenunderageof15years,pregnantfemales,and
patients who received renal replacement therapy previously
were excluded from the study. This trial recruited 70
patients over a period of ﬁve years (1993–1998). PD was
performed by use of rigid peritoneal catheter done under
local anesthesia, and open drainage system was used with
dwell time of 30 minutes. Daily PD ﬂuid volume of 70L was
used. Hemoﬁltration was performed through insertion of
femoralcatheteratbloodﬂow rateof150cc/min,andCVVH
eﬄuent rate was approximately 25L/day. Renal replacement
therapy was continued till attending physician decided that
it was no longer indicated. Duration of Hemoﬁltration was
half as compared to duration of peritoneal dialysis. Results
of the study showed that rate of correction of metabolic
abnormalities was twice as fast in Hemoﬁltration group as
compared to patients on peritoneal dialysis. Mortality rate
of patients (one of the secondary end points in the study)
on Peritoneal Dialysis was 47% compared to 15% on CRRT.
The need for further renal replacement therapy (another
secondary end point) was higher in survivors of PD than
those of Hemoﬁltration. This trial had a small number of
patients in shock (3% versus 5% in PD and Hemoﬁltration
group, resp.). However, use of intermittent PD with rigid
catheters, an open drainage system, and manual exchanges
may have led to inadequate solute clearance and hence
high mortality rate in the PD group. Interestingly, the same
authors had published another study in 1992 showing a
signiﬁcant reduction in mortality of AKI patients treated
with acute PD associated with malaria. In this study, PD
was the only modality used as there was no other dialytic
modality available in this tertiary care [51].
Another prospective, randomized, controlled trial from
Brazil compared high volume Peritoneal Dialysis (HVPD)
with daily Hemodialysis (DHD) in RRT of AKI due to
ischemic ATN associated with sepsis in the majority of the
patients [52, 53]. The primary outcome in this study was
to compare patient outcome for mortality rate and recovery
of renal function. Secondary end point was to examine
the adequacy of HVPD and DHD in relation to metabolic
control. In this study, intermittent Hemodialysis was given 6
days a week with targets Kt/V of 1.2 even though delivered
dialysis dose was much lower in HVPD patient (weekly Kt/V
= 3.6) as compared to DHD group (weekly Kt/V = 4.8).
Peritoneal dialysis was performed 24 hours a day 7 days per
week by using a ﬂexible peritoneal dialysis catheter with 30–
55-minute dwell time assisted with use of automated cycler.
The prescribed Kt/V value was 0.65 in CPD group and total
of36–44LperdayofPDﬂuidwasused.DHDwasperformed
daily with at least 3-hour session six times a week using
double lumen temporary dialysis catheter. A total of 120
patients out of 154 completed the trial from 2004 to 2006
with 60 patients enrolled in each arm of the study. 70%
of the enrolled patients had hemodynamic instability. Mean
number of sessions was 5.5 in HVPD and 7.5 in DHDgroup.
Hospital mortality was 58% in patients who were treated
with high volume peritoneal dialysis and 53% in patients
who wererandomlyassigned todailyhemodialysis(P = .71).
83% of surviving patients in the peritoneal dialysis group
recovered kidney function as compared with 77% in the
hemodialysis group and time torenal recovery was shorter in
HVPDgroupascomparedtoDHD(7.2±2.6versus10.6±4.7
days, P = .04). Rate of catheter-related infection was similar
between the two groups. There was no signiﬁcant diﬀerence
in patient survival after 30 days of treatment (50% survival
rate in each group). This outcome is diﬀerent from the study
mentioned earlier.
There are no studies comparing the outcome of peri-
toneal dialysis as compared to alternate day intermittent
hemodialysis in AKI. Hence, peritoneal dialysis remains an
acceptable alternative to hemodialysis and CRRT especially
in countries where technology for IHD and CRRT is not
readily available.
9.Conclusion
Peritoneal dialysis has been in use since 1970 in patients
with acute kidney injury especially those who are hemody-
namically unstable or at risk of bleeding because of bleeding
tendency, in pediatric patients with acute kidney injury, and
in patients with vascular access failure.
Peritoneal dialysis remains an eﬀective therapy which is
simple and easy to use. This is especially the case for infants
and children with AKI both in ICU and non-ICU settings,
although its use is less preferable in western countries
especially with advent of newer options available for CRRT
like SLED and CVVDHF. It is a less eﬀective modalityInternational Journal of Nephrology 9
in certain clinical situations like patients with poisoning,
hypercatabolic states, and pulmonary edema. There is a
limited data concerning the eﬀect on mortality of PD versus
otherRRTtherapieslikeintermittenthemodialysis andother
continuous renal replacement therapies in patients with
acute kidney injury.
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